Table: Oncolys Biopharma -2021 parent results

Oncolys Biopharma

10/02/2022 06:01

Feb 10 (Reuters)- 
          Oncolys Biopharma Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended        Year to        NEXT   
              Dec 31, 2021     Dec 31, 2020    Dec 31, 2022      YEAR     
                 LATEST          YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS         FORECAST     H1 FORECAST 
  Sales          642 mln         314 mln           1.00                   
              (+104.5 pct)     (-75.9 pct)     (+155.7 pct)               
  Operating     loss 1.45       loss 1.67        loss 1.60                
  Recurring     loss 1.50       loss 1.72        loss 1.60                
  Net           loss 1.62       loss 2.10        loss 1.60                
  EPS        loss 95.50 yen  loss 145.58 yen  loss 94.59 yen              
  Ann Div          NIL             NIL              NIL                   
  -Q2 Div          NIL             NIL              NIL                   
  -Q4 Div          NIL             NIL              NIL                   
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T